Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lung Deposition of OligoG in Cystic Fibrosis
NCT01991028Phase 2Completed
- Sponsor
- BDD Pharma
- Start
- Apr 2014
- Primary completion
- Sep 2014
- Modality
- Oligosaccharide
- Countries
- 1
01
Overview
A Phase 2 trial of OligoG in cystic fibrosis (CF), sponsored by BDD Pharma. Started Apr 2014; status: completed.
02
Drugs
OligoG
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT01991028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01991028.